Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 195

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Limited Resection for the Treatment of Patients With Stage IA Lung Cancer

Wisnivesky, Juan P., Henschke, Claudia I., Swanson, Scott, Yankelevitz, David F., Zulueta, Javier, Marcus, Sue, Halm, Ethan A.·2010·Annals of Surgery

Abstract

In Brief Objective: Lobectomy is the standard of care for stage IA lung cancer. Some small retrospective studies have suggested similar results after limited resection for tumors ≤2 cm in size. The objective of the study was to compare survival after lobectomy and limited resection among Medicare patients with lung cancer. Methods: Using the Surveillance, Epidemiology, and End Results registry, linked to Medicare records, we identified 1165 cases of stage I lung cancer ≤2 cm in size that underwent lobectomy or limited resection (segmentectomy or wedge resection). We used logistic regression to determine propensity scores for undergoing limited resection based on the patients' preoperative characteristics. Overall and lung cancer-specific survival of patients treated with lobectomy or limited resection was compared after adjusting for their propensity score. Results: Overall, 196 (17%) patients underwent limited resection. For the entire sample, the adjusted hazard ratio for all cause mortality (1.09; 95% confidence interval: 0.85–1.40) or lung cancer-specific death (hazard ratio: 1.39; 95% confidence interval: 0.97–2.01) for patients undergoing limited resection were not significantly different from those having lobectomy. Similarly, we found no significant differences in overall or lung cancer-specific survival for patients treated with limited resection compared with lobectomy when data was analyzed stratifying and matching patients by their propensity scores. Conclusions: These results suggest that survival of patients >65 years of age undergoing limited resection or lobectomy for stage IA tumors ≤2 cm appears to be similar. Although these findings should be confirmed in prospective trials, our results suggest that limited resection may be an effective therapeutic alternative for these patients. Using population-based data, we compared the survival of 1165 patients with stage I lung cancer ≤2 cm in size that underwent lobectomy, the standard of care, or limited resection. Propensity scores analyses showed that overall and lung cancer-specific survival for patients undergoing limited resection were not significantly different from those receiving lobectomy. These results suggest that limited resection may be an effective therapeutic alternative for these patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/sla.0b013e3181c0e5f3

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 195

Metadata

Authors
Wisnivesky, J. P., Henschke, C. I., Swanson, S., Yankelevitz, D. F., Zulueta, J., Marcus, S., & Halm, E. A.
Venue
Annals of Surgery
Published
2010-03
Volume
251
Issue
3
Pages
550-554
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2055903629
Cited by
195
References
2
FWCI
8.12
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Limited Resection for the Treatment of Patients With Stage IA Lung Cancer. https://app.cochat.ai/papers/10.1097/sla.0b013e3181c0e5f3
The paper
Wisnivesky, J. P., Henschke, C. I., Swanson, S., Yankelevitz, D. F., Zulueta, J., Marcus, S., & Halm, E. A. (2010). Limited Resection for the Treatment of Patients With Stage IA Lung Cancer. Annals of Surgery. https://doi.org/10.1097/sla.0b013e3181c0e5f3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.